Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

Leukemia. 2021 Jun;35(6):1745-1750. doi: 10.1038/s41375-020-01022-2. Epub 2020 Sep 18.
No abstract available

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blood Transfusion / mortality*
  • Female
  • Follow-Up Studies
  • Humans
  • Iron / adverse effects*
  • Iron Overload / etiology
  • Iron Overload / metabolism
  • Iron Overload / mortality*
  • Iron Overload / pathology
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / mortality*
  • Myelodysplastic Syndromes / pathology
  • Myelodysplastic Syndromes / therapy
  • Prognosis
  • Prospective Studies
  • Survival Rate

Substances

  • Iron